Enhancer of mRNA Decapping protein 4 (EDC4) interacts with replication protein a (RPA) and contributes to Cisplatin resistance in cervical Cancer by alleviating DNA damage
Abstract Background Cervical cancer (CC) is the third most common gynecological malignancy around the world. Cisplatin is an effective drug, but cisplatin resistance is a vital factor limiting the clinical usage of cisplatin. Enhancer of mRNA decapping protein 4 (EDC4) is a known regulator of mRNA d...
Main Authors: | Xiaoling Wu, Youwen Zhong, Qing Chen, Xin Zhang, Hua Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Hereditas |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41065-020-00154-w |
Similar Items
-
Crosstalk between Edc4 and Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling in mRNA Decapping
by: Hazir Rahman, et al.
Published: (2014-12-01) -
Functional analysis of an alternative Replication Protein A complex containing RPA4
by: Mason, Aaron Charles
Published: (2010) -
A non-canonical role for the EDC4 decapping factor in regulating MARF1-mediated mRNA decay
by: William R Brothers, et al.
Published: (2020-06-01) -
General decapping activators target different subsets of inefficiently translated mRNAs
by: Feng He, et al.
Published: (2018-12-01) -
The decapping activator Edc3 and the Q/N-rich domain of Lsm4 function together to enhance mRNA stability and alter mRNA decay pathway dependence in Saccharomyces cerevisiae
by: Susanne Huch, et al.
Published: (2016-10-01)